Class 3 Medicines Recall: Lynparza 50mg capsules (olaparib)

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 3 medicines recall for specific batches of Lynparza 50mg capsules (olaparib).
Source: Royal Pharmaceutical Society News - Category: Drugs & Pharmacology Source Type: news